结核分枝杆菌丙氨酸消旋酶的单体-二聚体平衡取决于缓冲条件

Shannon Stirling, S. Majumdar, J. Ko, J. C. Ford
{"title":"结核分枝杆菌丙氨酸消旋酶的单体-二聚体平衡取决于缓冲条件","authors":"Shannon Stirling, S. Majumdar, J. Ko, J. C. Ford","doi":"10.22186/JYI.36.4.50-54","DOIUrl":null,"url":null,"abstract":"(Azam and Jayaram, 2016). Several known inhibitors of M. tuberculosis ALR (Mt-ALR) work by binding to the substrate-binding site proximal to the bound PLP (Anthony et al., 2011). Among known inhibitors of Mt-ALR, only D-cycloserine, a substrate analog, is used medically to treat TB. However, D-cycloserine carries substantial side effects because it inactivates ALR by binding to the enzyme-bound PLP and PLP-dependent enzymes are essential for many eukaryotic systems. In humans, PLP is important for proper neural functioning. Disruption of PLP binding has led to reports of dizziness, coma, depression, and other neurological and psychotic disorders in D-cycloserine users (Walsh, 2003). Anthony et al. (2011) have identified new classes of ALR inhibitors by high-throughput screening of 53,000 compounds. Upon analyzing synthetic compound libraries, 472 hits were found, with only 25 strong hits. All of the hits came from the synthetic compound libraries analyzed; their strategy was to select inhibitors that are not substrate analogs. Similarly, to avoid selecting the inhibitors that are substrate analogs, some authors have suggested the inclusion of conserved residues at the entrance to the catalytic pocket of Mt-ALR as additional targets in structure-aided drug design (LeMagueres et al., 2005). Others have suggested designing inhibitors that bind to the dimer interface to block dimerization (Azam and Jayaram, 2016). One of the goals of the current study was to understand the dimerization of ALRs and thus aid in the design of inhibitors, which could serve as drugs, that work by interfering with the dimerization of Mt-ALR. ALR has long been recognized as a potential target for drug design (Silverman, 1988). While some species show monomeric ALR, most ALR exhibit dimeric forms (Ju et al., 2011). Yokoigawa et al. (2003) first reported a dynamic monomer-dimer equilibrium in the case of ALR from 4 Shigella species. Ju et al. (2005) Monomer-dimer Equilibrium of Mycobacterium tuberculosis Alanine Racemase Depends on Buffer Conditions","PeriodicalId":74021,"journal":{"name":"Journal of young investigators","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Monomer-dimer Equilibrium of Mycobacterium tuberculosis Alanine Racemase Depends on Buffer Conditions\",\"authors\":\"Shannon Stirling, S. Majumdar, J. Ko, J. C. Ford\",\"doi\":\"10.22186/JYI.36.4.50-54\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"(Azam and Jayaram, 2016). Several known inhibitors of M. tuberculosis ALR (Mt-ALR) work by binding to the substrate-binding site proximal to the bound PLP (Anthony et al., 2011). Among known inhibitors of Mt-ALR, only D-cycloserine, a substrate analog, is used medically to treat TB. However, D-cycloserine carries substantial side effects because it inactivates ALR by binding to the enzyme-bound PLP and PLP-dependent enzymes are essential for many eukaryotic systems. In humans, PLP is important for proper neural functioning. Disruption of PLP binding has led to reports of dizziness, coma, depression, and other neurological and psychotic disorders in D-cycloserine users (Walsh, 2003). Anthony et al. (2011) have identified new classes of ALR inhibitors by high-throughput screening of 53,000 compounds. Upon analyzing synthetic compound libraries, 472 hits were found, with only 25 strong hits. All of the hits came from the synthetic compound libraries analyzed; their strategy was to select inhibitors that are not substrate analogs. Similarly, to avoid selecting the inhibitors that are substrate analogs, some authors have suggested the inclusion of conserved residues at the entrance to the catalytic pocket of Mt-ALR as additional targets in structure-aided drug design (LeMagueres et al., 2005). Others have suggested designing inhibitors that bind to the dimer interface to block dimerization (Azam and Jayaram, 2016). One of the goals of the current study was to understand the dimerization of ALRs and thus aid in the design of inhibitors, which could serve as drugs, that work by interfering with the dimerization of Mt-ALR. ALR has long been recognized as a potential target for drug design (Silverman, 1988). While some species show monomeric ALR, most ALR exhibit dimeric forms (Ju et al., 2011). Yokoigawa et al. (2003) first reported a dynamic monomer-dimer equilibrium in the case of ALR from 4 Shigella species. Ju et al. (2005) Monomer-dimer Equilibrium of Mycobacterium tuberculosis Alanine Racemase Depends on Buffer Conditions\",\"PeriodicalId\":74021,\"journal\":{\"name\":\"Journal of young investigators\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of young investigators\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22186/JYI.36.4.50-54\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of young investigators","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22186/JYI.36.4.50-54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

(Azam和Jayaram,2016)。几种已知的结核分枝杆菌ALR抑制剂(Mt ALR)通过与结合的PLP附近的底物结合位点结合而发挥作用(Anthony等人,2011)。在已知的Mt ALR抑制剂中,只有底物类似物D-环丝氨酸在医学上用于治疗结核病。然而,D-环丝氨酸具有显著的副作用,因为它通过与酶结合的PLP结合来灭活ALR,并且PLP依赖性酶对许多真核生物系统是必不可少的。在人类中,PLP对正常的神经功能很重要。PLP结合的破坏导致D-环丝氨酸使用者出现头晕、昏迷、抑郁和其他神经和精神障碍的报告(Walsh,2003)。Anthony等人(2011)通过高通量筛选53000种化合物,确定了新型ALR抑制剂。在分析合成化合物库时,发现472个点击,只有25个强烈点击。所有的点击都来自所分析的合成化合物库;他们的策略是选择不是底物类似物的抑制剂。类似地,为了避免选择底物类似物抑制剂,一些作者建议在结构辅助药物设计中,在Mt ALR的催化袋入口处包含保守残基作为额外的靶标(LeMagueres等人,2005)。其他人建议设计与二聚体界面结合的抑制剂来阻断二聚作用(Azam和Jayaram,2016)。当前研究的目标之一是了解ALR的二聚化,从而有助于设计抑制剂,这些抑制剂可以作为药物,通过干扰Mt ALR的二聚作用发挥作用。长期以来,ALR一直被认为是药物设计的潜在靶点(Silverman,1988)。虽然一些物种表现出单体ALR,但大多数ALR表现出二聚体形式(Ju等人,2011)。Yokoigawa等人(2003)首次报道了4种志贺菌ALR情况下的动态单体-二聚体平衡。Ju等人(2005)结核分枝杆菌丙氨酸外消旋酶的单体-二聚体平衡取决于缓冲条件
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Monomer-dimer Equilibrium of Mycobacterium tuberculosis Alanine Racemase Depends on Buffer Conditions
(Azam and Jayaram, 2016). Several known inhibitors of M. tuberculosis ALR (Mt-ALR) work by binding to the substrate-binding site proximal to the bound PLP (Anthony et al., 2011). Among known inhibitors of Mt-ALR, only D-cycloserine, a substrate analog, is used medically to treat TB. However, D-cycloserine carries substantial side effects because it inactivates ALR by binding to the enzyme-bound PLP and PLP-dependent enzymes are essential for many eukaryotic systems. In humans, PLP is important for proper neural functioning. Disruption of PLP binding has led to reports of dizziness, coma, depression, and other neurological and psychotic disorders in D-cycloserine users (Walsh, 2003). Anthony et al. (2011) have identified new classes of ALR inhibitors by high-throughput screening of 53,000 compounds. Upon analyzing synthetic compound libraries, 472 hits were found, with only 25 strong hits. All of the hits came from the synthetic compound libraries analyzed; their strategy was to select inhibitors that are not substrate analogs. Similarly, to avoid selecting the inhibitors that are substrate analogs, some authors have suggested the inclusion of conserved residues at the entrance to the catalytic pocket of Mt-ALR as additional targets in structure-aided drug design (LeMagueres et al., 2005). Others have suggested designing inhibitors that bind to the dimer interface to block dimerization (Azam and Jayaram, 2016). One of the goals of the current study was to understand the dimerization of ALRs and thus aid in the design of inhibitors, which could serve as drugs, that work by interfering with the dimerization of Mt-ALR. ALR has long been recognized as a potential target for drug design (Silverman, 1988). While some species show monomeric ALR, most ALR exhibit dimeric forms (Ju et al., 2011). Yokoigawa et al. (2003) first reported a dynamic monomer-dimer equilibrium in the case of ALR from 4 Shigella species. Ju et al. (2005) Monomer-dimer Equilibrium of Mycobacterium tuberculosis Alanine Racemase Depends on Buffer Conditions
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Automated Exposure Notification for COVID-19. Does Providing Hiding Spaces for Zebrafish in Large Groups Reduce Aggressive Behaviour? Structural Analysis of a New Saccharomyces cerevisiae α-glucosidase Homology Model and Identification of Potential Inhibitor Enzyme Docking Sites The Engineering of Natural Killer Cells as an Emerging Adoptive Cancer Immunotherapy A Novel Nickel-Titanium Wire-Actuated Prosthetic Motor Clutch
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1